| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 100447-70-9 | Iron,dodecacarbonyltri-, triangulo; Iron dodecacarbonyl, stabilised with 5-10% methanol, 95% |  | C12FeO12 | 詳情 | 供應(yīng)商 | |
| 164740-75-4 | Iturin C3 (9CI); A 2822b; Cyclo(14-methyl-3-aminopentadecanoyl-L-a-aspartyl-D-tyrosyl-D-asparaginyl-L-glutaminyl-L-prolyl-D-asparaginyl-L-seryl) |  | C50H77N11O15 | 詳情 | 供應(yīng)商 | |
| 84731-55-5 | Isooctadecanoic acid,lithium salt (9CI); Isostearicacid lithium salt |  | C18H35LiO2 | 詳情 | 供應(yīng)商 | |
| 91305-43-0 | Isoxazolo[5,4-c]pyridine-3,7(2H,4H)-dione,5,6-dihydro-; Isoxazolo[5,4-c]pyridine-3,7(2H,4H)-dione, 5,6-dihydro- (9CI) |  | C6H6N2O3 | 詳情 | 供應(yīng)商 | |
| 91305-31-6 | Isoxazolo[5,4-c]pyridin-3(2H)-one,4,5,6,7-tetrahydro-5-methyl-; Isoxazolo[5,4-c]pyridin-3(2H)-one, 4,5,6,7-tetrahydro-5-methyl- (9CI) |  | C7H10N2O2 | 詳情 | 供應(yīng)商 | |
| 91305-30-5 | Isoxazolo[5,4-c]pyridin-3(2H)-one,4,5,6,7-tetrahydro-7-methyl-; Isoxazolo[5,4-c]pyridin-3(2H)-one, 4,5,6,7-tetrahydro-7-methyl- (9CI) |  | C7H10N2O2 | 詳情 | 供應(yīng)商 | |
| 76267-24-8 | Imidodicarbonicdiamide, 2-methyl-N-(1-methylethyl)-N'-phenyl-; 1-Isopropyl-3-methyl-5-phenylbiuret |  | C12H17N3O2 | 詳情 | 供應(yīng)商 | |
| 93982-40-2 | Imidodicarbonimidicdiamide, N-[2-hydroxy-3-(2-propen-1-yloxy)propyl]-; Imidodicarbonimidicdiamide, N-[2-hydroxy-3-(2-propenyloxy)propyl]- (9CI) |  | C8H17N5O2 | 詳情 | 供應(yīng)商 | |
| 16448-54-7 | Iron,[N,N-bis[(carboxy-kO)methyl]glycinato(3-)-kN,kO]-, (T-4)-; Aceticacid, nitrilotri-, iron complex (6CI); Iron, (nitrilotriacetato)- (7CI,8CI); Iron, [N,N-bis(carboxymethyl)glycinato(3-)-N,O,O',O'']-, (T-4)-; Fe(III)-NTAcomplex (1:1); Ferric nitrilotriacetate; Iron nitrilotriacetate; Iron(III)nitrilotriacetate; Iron, [nitrilotriacetato(3-)]; Iron-nitrilotriacetic acidchelate |  | C6H6FeNO6 | 詳情 | 供應(yīng)商 | |
| 107605-03-8 | Imidazo[2,1-b]quinazolin-5(1H)-one,3-(4-bromophenyl)-1-(4-hydroxyphenyl)- |  | C22H14BrN3O2 | 詳情 | 供應(yīng)商 | |
| 2978-35-0 | Imidodicarbonimidicdiamide, N-cyano-; Biguanide,1-cyano- (7CI); Biguanide, 2-cyano- (8CI); Cyanobiguanide |  | C3H6N6 | 詳情 | 供應(yīng)商 | |
| 345911-06-0 | Isoxazole,3-methyl-5-[(Z)-3-pyrrolidinylidenemethyl]-; Isoxazole, 3-methyl-5-[(Z)-3-pyrrolidinylidenemethyl]- (9CI) |  | C9H12N2O | 詳情 | 供應(yīng)商 | |
| 63775-93-9 | Isocyclosporin D (9CI); IsocyclosporinA, 1-[N-[3-hydroxy-4-methyl-2-(methylamino)-1-oxo-6-octenyl]-L-valine]-,[2S-(2R*,3S*,4S*,6E)]-; 1-Oxa-4,7,10,13,16,19,22,25,28,31-decaazacyclotetratriacontane,cyclic peptide deriv.; L-Valine,N-[3-hydroxy-4-methyl-2-(methylamino)-1-oxo-6-octenyl]-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-,q1-lactone, [2S-(2R*,3S*,4S*,6E)]- |  | C63H113N11O12 | 詳情 | 供應(yīng)商 | |
| 14970-06-0 | Iridium,bromocarbonylbis(triphenylphosphine)-; Bromocarbonylbis(triphenylphosphine)iridium |  | C37H30BrIrOP2 | 詳情 | 供應(yīng)商 | |
| 165611-01-8 | Isoxazolo[4,5-d]pyrimidine-3-carboxamide,5-(chloromethyl)-7-phenyl-; 3-Carbamido-5-chloromethyl-7-phenylisoxazolo(4,5-d)pyrimidine |  | C13H9ClN4O2 | 詳情 | 供應(yīng)商 | |
| 15589-64-7 | Isoquinolinium,2-(3-sulfopropyl)-, inner salt; 2-(3-Sulfopropyl)isoquinoliniumhydroxide, inner salt (6CI); Isoquinolinium, 2-(3-sulfopropyl)-, hydroxide, innersalt (8CI) |  | C12H13NO3S | 詳情 | 供應(yīng)商 | |
| 116988-01-3 | Indolo[2,3-a]quinolizin-4(6H)-one,7,12-dihydro-10-methoxy-; Harmalanine |  | C16H14N2O2 | 詳情 | 供應(yīng)商 | |
| 108906-92-9 | Isoleucine,N-formylisoleucyl-3-[3-(2-aminoethenyl)-4-methoxyphenoxy]prolyl-, (3®2)-lactam; SativanineK |  | C27H38N4O6 | 詳情 | 供應(yīng)商 | |
| 63937-56-4 | Isoquinoline,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[2-(2-nitrophenyl)ethyl]-; Isoquinoline,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(o-nitrophenethyl)- (7CI) |  | C20H24N2O4 | 詳情 | 供應(yīng)商 | |
| 174497-84-8 | Isoxazolidine,5-ethoxy-2-(1-methylethyl)-; Isoxazolidine, 5-ethoxy-2-(1-methylethyl)- (9CI) |  | C8H17NO2 | 詳情 | 供應(yīng)商 | |